Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HPGD | P15428 | 3/20 | 0.92 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.92 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.92 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.92 |
| ▸ | LMNA | P02545 | 3/20 | 0.71 |
| ▸ | PDXK | O00764 | 3/20 | 0.56 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.54 |
| ▸ | MEN1 | O00255 | 1/20 | 0.54 |
| ▸ | AOX1 | Q06278 | 1/20 | 0.54 |
| ▸ | TRIM24 | O15164 | 1/20 | 0.53 |
| ▸ | TRIM33 | Q9UPN9 | 1/20 | 0.53 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.52 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.52 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.52 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.52 |
| ▸ | GAA | P10253 | 1/20 | 0.48 |
| ▸ | CA1 | P00915 | 3/20 | 0.44 |
| ▸ | CA2 | P00918 | 3/20 | 0.44 |
| ▸ | CA9 | Q16790 | 3/20 | 0.44 |
| ▸ | NPC1 | O15118 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Pyridoxine SCHEMBL3506 | 0.96 | HPGD (1.00) | HPGDKDM4EALDH1A1HSD17B10LMNA | |
| Pyridoxine SCHEMBL30877002 | 0.96 | HPGD (1.00) | HPGDKDM4EALDH1A1HSD17B10LMNA | |
| Pyridoxine SCHEMBL30267871 | 0.96 | HPGD (1.00) | HPGDKDM4EALDH1A1HSD17B10LMNA | |
| Pyridoxine SCHEMBL2322958 | 0.96 | HPGD (1.00) | HPGDKDM4EALDH1A1HSD17B10LMNA | |
| Pyridoxine SCHEMBL10659848 | 0.94 | HPGD (0.96) | HPGDKDM4EALDH1A1HSD17B10LMNA | |
| Pyridoxine SCHEMBL3640160 | 0.94 | HPGD (0.96) | HPGDKDM4EALDH1A1HSD17B10LMNA | |
| Pyridoxine SCHEMBL15769549 | 0.94 | KDM4E (0.96) | HPGDKDM4EALDH1A1HSD17B10LMNA | |
| Pyridoxine SCHEMBL3332830 | 0.94 | KDM4E (0.96) | HPGDKDM4EALDH1A1HSD17B10LMNA | |
| Pyridoxine SCHEMBL444525 | 0.94 | KDM4E (0.96) | HPGDKDM4EALDH1A1HSD17B10LMNA | |
| Pyridoxine SCHEMBL42293 | 0.94 | KDM4E (0.96) | HPGDKDM4EALDH1A1HSD17B10LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 37 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220184010-A1 | ANTIVIRAL COMPOSITIONS AND METHODS FOR INACTIVATING NON-ENVELOPED VIRUSES USING ALKYL 2-HYDROXYCARBOXYLIC ACIDS | ECOLAB USA INC. | 2022-06-16 | — | — | US | disclosed |
| US-20200330413-A1 | ANTIVIRAL COMPOSITIONS AND METHODS FOR INACTIVATING NON-ENVELOPED VIRUSES USING ALKYL 2-HYDROXYCARBOXYLIC ACIDS | ECOLAB USA INC. | 2020-10-22 | — | — | US | disclosed |
| US-10736860-B2 | Antiviral compositions and methods for inactivating non-enveloped viruses using alkyl 2-hydroxycarboxylic acids | ECOLAB USA INC. (US) | 2020-08-11 | — | — | US | disclosed |
| EP-2968631-B1 | AROMATIC CARBOXYLIC ACIDS IN COMBINATION WITH AROMATIC HYDROXYAMIDES FOR INACTIVATING NON-ENVELOPED VIRUSES | ECOLAB USA INC (US) | 2019-05-22 | — | — | EP | disclosed |
| US-20180036266-A1 | ANTIVIRAL COMPOSITIONS AND METHODS FOR INACTIVATING NON-ENVELOPED VIRUSES USING ALKYL 2-HYDROXYCARBOXYLIC ACIDS | ECOLAB USA INC. | 2018-02-08 | — | — | US | disclosed |
| US-9808435-B2 | Antiviral compositions and methods for inactivating non-enveloped viruses using alkyl 2-hydroxycarboxylic acids | ECOLAB USA INC. (US) | 2017-11-07 | — | — | US | disclosed |
| US-9393252-B2 | Aromatic carboxylic acids in combination with aromatic hydroxyamides for inactivating non-enveloped viruses | ECOLAB USA INC. (US) | 2016-07-19 | — | — | US | disclosed |
| EP-2968631-A1 | AROMATIC CARBOXYLIC ACIDS IN COMBINATION WITH AROMATIC HYDROXYAMIDES FOR INACTIVATING NON-ENVELOPED VIRUSES | Ecolab USA Inc. (US) | 2016-01-20 | — | — | EP | disclosed |
| WO-2014164021-A1 | ANTIVIRAL COMPOSITIONS AND METHODS FOR INACTIVATING NON-ENVELOPED VIRUSES USING ALKYL 2-HYDROXYCARBOXYLIC ACIDS | ECOLAB USA INC. (US) | 2014-10-09 | — | — | WO | disclosed |
| WO-2014158761-A1 | AROMATIC CARBOXYLIC ACIDS IN COMBINATION WITH AROMATIC HYDROXYAMIDES FOR INACTIVATING NON-ENVELOPED VIRUSES | ECOLAB USA INC. (US) | 2014-10-02 | — | — | WO | disclosed |
| US-20050148570-A1 | Novel substituted alkane compounds and uses thereof | HUANG LIREN (US) | 2005-07-07 | — | — | US | disclosed |
| WO-2005051342-A1 | ANTIMICROBIAL COMPOSITIONS CONTAINING AN AROMATIC CARBOXYLIC ACID AND A HYDRIC SOLVENT | THE DIAL CORPORATION (US) | 2005-06-09 | — | — | WO | disclosed |
| US-20050113276-A1 | Antimicrobial compositions containing an aromatic carboxylic acid and a hydric solvent | HENKEL AG & CO. KGAA (DE) | 2005-05-26 | — | — | US | disclosed |
| EP-1453913-A2 | NOVEL SUBSTITUTED ALKANE COMPOUNDS AND USES THEREOF | Antex Pharma, Inc. (US) | 2004-09-08 | — | — | EP | disclosed |
| US-20030216479-A1 | Novel compositions comprising 2,2-Bis (4-hydroxy-3-methylphenyl) heptane and uses thereof | BIOPORT R&D, INC. | 2003-11-20 | — | — | US | disclosed |
| WO-2003062443-A2 | NOVEL SUBSTITUTED ALKANE COMPOUNDS AND USES THEREOF | ANTEX PHARMA, INC. (US) | 2003-07-31 | — | — | WO | disclosed |
| EP-1191843-A2 | ANTIBACTERIAL COMPOSITIONS | The Dial Corporation (US) | 2002-04-03 | — | — | EP | disclosed |
| US-6204230-B1 | IN ANTIBACTERIAL CLEANSING COMPOSITIONS USED TO CLEANSE SKIN AND TO DESTROY BACTERIA AND OTHER MICROORGANISMS PRESENT ON THE SKIN, ESPECIALLY THE HANDS, ARMS, AND FACE OF THE USER OR FOR CLEAING HARD SURFACES | THE DIAL CORPORATION | 2001-03-20 | — | — | US | disclosed |
| WO-2000078275-A2 | ANTIBACTERIAL COMPOSITIONS | THE DIAL CORPORATION (US) | 2000-12-28 | — | — | WO | disclosed |
| US-6136771-A | COMPRISING PHENOLIC ANTIBACTERIAL AGENT, DISINFECTING ALCOHOL, GELLING AGENT, WATER | THE DIAL CORPORATION (US) | 2000-10-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050148570-A1 | Novel substituted alkane compounds and uses thereof | ALK, CYP11B2, ALKBH2 | HPGD 1645/4885KDM4E 3170/4885ALDH1A1 44/4885 |
| US-10736860-B2 | Antiviral compositions and methods for inactivating non-enveloped viruses using alkyl 2-hydroxycarboxylic acids | CUTA, HAVCR2, SDC2 | HPGD 2329/4885KDM4E 853/4885ALDH1A1 1398/4885 |
| US-20180036266-A1 | ANTIVIRAL COMPOSITIONS AND METHODS FOR INACTIVATING NON-ENVELOPED VIRUSES USING ALKYL 2-HYDROXYCARBOXYLIC ACIDS | CUTA, HAVCR2, SDC2 | HPGD 2329/4885KDM4E 853/4885ALDH1A1 1398/4885 |
| US-20200330413-A1 | ANTIVIRAL COMPOSITIONS AND METHODS FOR INACTIVATING NON-ENVELOPED VIRUSES USING ALKYL 2-HYDROXYCARBOXYLIC ACIDS | CUTA, HAVCR2, SDC2 | HPGD 2329/4885KDM4E 853/4885ALDH1A1 1398/4885 |
| US-20220184010-A1 | ANTIVIRAL COMPOSITIONS AND METHODS FOR INACTIVATING NON-ENVELOPED VIRUSES USING ALKYL 2-HYDROXYCARBOXYLIC ACIDS | CUTA, HAVCR2, SDC2 | HPGD 2329/4885KDM4E 853/4885ALDH1A1 1398/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.